Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DiaceuticsDIUXF 85 Intrinsic Value: Projected FCF is $-0.43 as of Aug. 23, 2026. GuruFocus rates DIUXF with a GF Score™ of 85/100 and a GF Value™ of $2.83. The stock has 1 warning sign investors should review. Among 344 Healthcare Providers & Services companies, Diaceutics ranks worse than 290697.38% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2026-08-23), Diaceutics's Intrinsic Value: Projected FCF is $-0.43. The stock price of Diaceutics is $2.00. Therefore, Diaceutics's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.
The historical rank and industry rank for Diaceutics's Intrinsic Value: Projected FCF or its related term are showing as below:
During the past 10 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Diaceutics was 18.88. The lowest was 18.88. And the median was 18.88.
DIUXF's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.08 * Ranked among companies with meaningful Price-to-Projected-FCF only.
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Diaceutics's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
2.00
/
-0.38294154139416
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diaceutics Intrinsic Value: Projected FCF Related Terms
Diaceutics Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Diaceutics's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DIUXF vs VEEV, BTSG, HQY: Intrinsic Value: Projected FCF Comparison
For the Health Information Services subindustry, Diaceutics's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diaceutics Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Diaceutics's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Diaceutics's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $-0.43 mean?
Diaceutics (DIUXF) has a Intrinsic Value: Projected FCF of $-0.43 as of Aug. 23, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Diaceutics and its competitors. Over the past decade, Diaceutics' Intrinsic Value: Projected FCF has ranged from 18.88 to 18.88. According to the industry distribution chart, Diaceutics ranks #999999 out of 344 companies in the Healthcare Providers & Services industry.
Is Diaceutics' Intrinsic Value: Projected FCF too high?
Diaceutics' current Intrinsic Value: Projected FCF is $-0.43. Over the past 10 years, this metric has ranged from a low of 18.88 to a high of 18.88. Based on the distribution chart, Diaceutics ranks #999999 out of 344 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Diaceutics has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Diaceutics' Intrinsic Value: Projected FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Diaceutics ranks #999999 out of 344 companies for Intrinsic Value: Projected FCF. This places Diaceutics in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 1.08. Historically, Diaceutics' own Intrinsic Value: Projected FCF has ranged from 18.88 to 18.88 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.08, based on 344 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Diaceutics and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diaceutics's current Intrinsic Value: Projected FCF is $-0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diaceutics stock overvalued right now?
Diaceutics (DIUXF) has a current Intrinsic Value: Projected FCF of $-0.43. The stock's GF Value™ is $2.83, compared to a current price of $2.00 — trading 29.3% below its estimated fair value. The current Intrinsic Value: Projected FCF is $-0.43. Diaceutics' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Diaceutics (DIUXF), the current Intrinsic Value: Projected FCF is $-0.43 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diaceutics (DIUXF) Overvalued in 2026?
Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued.
The current stock price of $2.00 is trading 29.3% below its estimated GF Value™ of $2.83.
Key valuation signals for DIUXF:
Intrinsic Value: Projected FCF: $-0.43
GF Value™: $2.83 vs. price of $2.00 (29.3% below fair value)
No single metric tells the full story. See the DIUXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
85GF Score
Get the complete analysis for DIUXF
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DIUXF has been successfully added to your 
